-
Product Name
Anti-Arylsulfatase A / ARSA antibody
- Documents
-
Description
Rabbit polyclonal to Arylsulfatase A / ARSA
-
Tested applications
ELISA, WB, IP
-
Species reactivity
Mouse Arylsulfatase-A / ARSA
-
Alternative names
Arsa antibody; ARSA antibody; Arylsulfatase A antibody; Arylsulfatase A antibody; As2 antibody; As-2 antibody; ASA antibody; AS-A antibody; AW212749 antibody; C230037L18Rik antibody; MLD antibody; TISP73 antibody; MLD antibody; ASA antibody; As2 antibody; AS-A antibody; As-2 antibody; TISP73 antibody; AW212749 antibody
- Immunogen
-
Isotype
Rabbit IgG
-
Preparation
Produced in rabbits immunized with purified, recombinant Mouse ARSA (rM ARSA; NP_033843.2; Met 1-Ser 506). ARSA specific IgG was purified by Mouse ARSA affinity chromatography.
-
Clonality
Polyclonal
-
Formulation
0.2 μm filtered solution in PBS with 5% trehalose
-
Storage instructions
This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free.
Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles. -
Applications
WB: 1-10 μg/mL
ELISA: 0.1-0.2 μg/mL
This antibody can be used at 0.1-0.2 μg/mL with the appropriate secondary reagents to detect Mouse ARSA. The detection limit for Mouse ARSA is approximately 0.00245 ng/well.
IP: 4-6 μg/mg of lysate
-
Validations
Arylsulfatase A / ARSA Antibody, Rabbit PAb, Antigen Affinity Purified, Western blot
Arylsulfatase A / ARSA Antibody, Rabbit PAb, Antigen Affinity Purified
-
Background
Arylsulfatase A (ARSA) is synthesized as a 52KDa lysosomal enzyme. It is a member of the sulfatase family that is required for the lysosomal degradation of cerebroside-3-sulfate, a sphingolipid sulfate ester and a major constituent of the myelin sheet. Arylsulfatase A is activated by a required co- or posttranslational modification with the oxidation of cysteine to formylglycine. Metachromatic leukodystrophy (MLD) is a lysosomal storage disease in the central and peripheral nervous systems with severe and progressive neurological symptoms caused by the deficiency of Arylsulfatase A. Deficiency of this enzyme is also found in apparently healthy individuals, a condition for which the term pseudodeficiency is introduced. ARSA forms dimers after receiving three N-linked oligosaccharides in the endoplasmic reticulum, and then the dimers are transported to the Golgi where they receive mannose 6-phosphate recognition markers. And thus, ARSA is transported and delivered to dense lysosomes in a mannose 6-phosphate receptor-dependent manner. It has been shown that within the lysosomes, the ARSA dimers can oligomerize to an octamer in a pH-dependent manner. The ARSA deficiency leads to metachromatic leucodystrophy (MLD), a lysosomal storage disorder associated with severe and progressive demyelination in he central and peripheral nervous system. Additionally, the serum level of arylsulfatase A might be helpful in diagnosis of lung and central nervous system cancer.
-
References
- Laidler PM. (1991) Arylsulfatase A--physico-chemical properties and the use of enzyme radioimmunoassay in medical diagnosis Folia Med Cracov. 32(3-4): 149-68.
- Jean S, et al. (2006) Ethanol decreases rat hepatic arylsulfatase A activity levels. Alcohol Clin Exp Res. 30(11): 1950-5.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"